Sign in

CIK 0001404281

  • Non-accelerated filer
  • Smaller reporting company

Eledon Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-238-8090
Business address
19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
Former names
Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-31 Perrin Steven President Grant or award +152,353 153,353
2026-07-31 Perrin Steven President Shares withheld for taxes −72,138 $3.38 $244K 81,215
2025-01-10 Perrin Steven President Grant or award · Stock Option (right to buy) +243,000 243,000
2025-01-10 Perrin Steven President Grant or award · Restricted Stock Units +27,000 27,000
2024-11-21 Perrin Steven President Grant or award · Stock Option (right to buy) +840,438 840,438
2024-06-13 Perrin Steven President Grant or award · Stock Option (right to buy) +428,148 428,148
2023-05-01 Perrin Steven President Grant or award · Stock Option (right to buy) +317,147 317,147
2023-02-01 Perrin Steven President Grant or award · Stock Option (right to buy) +155,000 155,000
2022-11-23 Perrin Steven President Purchase +1,000 $2.60 $3K 1,000
2022-02-01 Perrin Steven President Grant or award · Stock Option (right to buy) +155,000 155,000

Page 1 of 1 · 10 trades